Enhanced Antiviral Activity of Acyclovir Loaded into Nanoparticles
Overview
Authors
Affiliations
The activity of antivirals can be enhanced by their incorporation in nanoparticulate delivery systems. Peculiar polymeric nanoparticles, based on a β-cyclodextrin-poly(4-acryloylmorpholine) monoconjugate (β-CD-PACM), are proposed as acyclovir carriers. The experimental procedure necessary to obtain the acyclovir-loaded nanoparticles using the solvent displacement preparation method will be described in this chapter. Fluorescent labeled nanoparticles are prepared using the same method for cellular trafficking studies. The biocompatibility assays necessary to obtain safe nanoparticles are reported. Section 4 of this chapter describes the assessment of the antiviral activity of the acyclovir-loaded nanoparticles.
Dimitriou T, Didaras N, Barda C, Skopeliti D, Kontogianni K, Karatasou K Foods. 2023; 12(10).
PMID: 37238799 PMC: 10217140. DOI: 10.3390/foods12101978.
Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications.
Prabhakar P, Khurana N, Vyas M, Sharma V, El-Saber Batiha G, Kaur H Pharmaceutics. 2023; 15(2).
PMID: 36839773 PMC: 9960567. DOI: 10.3390/pharmaceutics15020451.
Identification of a βCD-Based Hyper-Branched Negatively Charged Polymer as HSV-2 and RSV Inhibitor.
Francese R, Cecone C, Costantino M, Hoti G, Bracco P, Lembo D Int J Mol Sci. 2022; 23(15).
PMID: 35955832 PMC: 9369026. DOI: 10.3390/ijms23158701.
Asdaq S, Ikbal A, Sahu R, Bhattacharjee B, Paul T, Deka B Nanomaterials (Basel). 2021; 11(7).
PMID: 34361227 PMC: 8308419. DOI: 10.3390/nano11071841.
Squillaci G, Zannella C, Carbone V, Minasi P, Folliero V, Stelitano D Molecules. 2021; 26(9).
PMID: 34067026 PMC: 8125794. DOI: 10.3390/molecules26092746.